Drugs with this side effect
- 1,25(OH)2D3
- 5-aza-2'-deoxycytidine: 4.94% - 8.08%
- 5-azacytidine
- Anidulafungin: 1.6% - 6.11%
- CGP 19835A: common
- FAMP: 0% - 1%
- K779: postmarketing
- L-Dmp: rare
- LiOH
- Lisinopril
- Lutalyse
- Mersyndol
- Metrodin: 0% - 2.7%
- NTBC
- Octreotide: uncommon
- PCI-32765
- PGE2
- Photofrin: 0% - 11%
- Photofrin II: very common, 4% - 12%
- Romidepsin: 2%
- SU5416
- UDCA
- VACV: 2%
- acyclovir: 2%
- afatinib: common
- amphotericin B
- anagrelide
- anthracycline
- apomorphine
- aprepitant
- aripiprazole
- arsenic trioxide
- atazanavir
- atropine
- axitinib: 6%
- azithromycin: postmarketing
- baclofen: uncommon
- bendamustine
- bexarotene
- bicalutamide
- bisacodyl
- boceprevir: common
- bortezomib: 0% - 18.4%
- bosentan
- bosutinib
- bumetanide
- buprenorphine
- bupropion
- cabazitaxel: 1% - 2%
- cabozantinib: 1% - 7%
- canagliflozin
- candesartan cilexetil
- capecitabine: 1% - 8%
- carboplatin
- carvedilol: 2.1%
- cefpodoxime
- cephem
- cetirizine
- cevimeline
- cidofovir
- cinacalcet: 0% - 24.1%
- cisplatin
- citalopram: rare
- clodronate
- clofarabine: common
- clomipramine: infrequent
- clonazepam
- codeine
- colchicine
- conivaptan: 2.2%
- cysteamine
- cytarabine: 10.7% - 18.2%
- dabrafenib: 0% - 11%
- dapagliflozin
- deferiprone: postmarketing
- delamanid
- deprenyl: infrequent
- desmopressin
- diazepam
- docetaxel: postmarketing, rare, 1% - 8%
- dolasetron
- donepezil: frequent, 2%
- doxazosin
- doxercalciferol
- doxorubicin: postmarketing, common
- duloxetine: postmarketing, infrequent, uncommon
- empagliflozin
- eplerenone: common
- eribulin: postmarketing
- erlotinib
- ertapenem
- eslicarbazepine acetate
- everolimus: common
- exenatide: postmarketing, rare
- febuxostat
- felbamate
- fentanyl: common, 0% - 21.1%
- ferumoxytol: postmarketing
- fludarabine: 0% - 1%
- fluoxetine: infrequent
- fluvoxamine: rare, infrequent
- formoterol
- foscarnet
- fosphenytoin: infrequent
- frovatriptan: infrequent
- furosemide: very common
- gabapentin
- galantamine: postmarketing, infrequent
- ganciclovir
- gefitinib: common
- glucose
- glucose solution
- glutamine: 0% - 18.8%
- glycine
- glycopyrrolate
- graphene
- histamine
- hydrocodone
- hydromorphone
- hydroxybutyrate
- icodextrin
- idarubicin
- iloperidone
- imatinib: infrequent, uncommon
- indapamide: postmarketing
- ioversol
- irinotecan: postmarketing, 4% - 15%
- itraconazole
- ixabepilone: 2%
- lactulose
- lamivudine
- lansoprazole
- lapatinib: very common
- lenalidomide: postmarketing, 2.99% - 7.46%
- leuprorelin acetate: 0% - 8.16%
- levetiracetam: 2%
- linaclotide
- liraglutide: postmarketing
- lisuride
- lithium
- lithium carbonate
- lomitapide
- mannitol
- meloxicam: 0% - 1.3%
- memantine: infrequent
- mesna: 2.5% - 7%
- metformin
- methylphenidate
- mirtazapine: infrequent
- misoprostol
- mitoxantrone
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- naltrexone
- naproxen
- naratriptan: infrequent
- nefazodone: infrequent
- nelarabine: 1% - 7%
- nelfinavir
- nilotinib: uncommon
- ofloxacin
- olanzapine: infrequent
- olsalazine
- oxaliplatin: very common, 3% - 11%
- oxycodone
- oxymorphone
- paclitaxel: postmarketing, rare, uncommon, common, 5%
- pantoprazole
- paricalcitol: 2.8% - 3%
- paroxetine: rare
- pazopanib
- pemetrexed: 0% - 9%
- pentosan polysulfate
- pergolide: infrequent
- phenytoin: infrequent
- pomalidomide: 2.68% - 4.67%
- ponatinib
- posaconazole: 0.718% - 11.3%
- pralatrexate
- pramipexole
- pregabalin: infrequent
- propafenone
- propofol
- quetiapine: infrequent
- rabeprazole
- radium
- raltitrexed: 3-4%
- ranolazine
- rapamycin
- reboxetine
- retinoic acid
- ribavirin: postmarketing, common
- rifaximin
- riluzole
- risperidone: rare
- ritonavir: postmarketing
- rivastigmine: postmarketing, frequent, 1% - 2%
- rizatriptan
- ropinirole: infrequent
- sacrosidase
- saquinavir
- sertraline: rare
- sibutramine
- sitaxsentan
- sodium
- sodium acetate
- sorafenib: postmarketing, uncommon
- sumatriptan: rare
- sunitinib
- tacrolimus: uncommon
- temozolomide: 1%
- temsirolimus
- thalidomide
- thiotepa
- tiagabine: infrequent
- tiotropium
- tipranavir: rare, 1.1%
- tobramycin
- tofacitinib
- tolcapone: infrequent
- tolvaptan: common
- topiramate: postmarketing, infrequent, frequent
- torasemide
- trabectedin
- tramadol: postmarketing, uncommon
- trametinib: 0% - 11%
- treprostinil
- valdecoxib
- valganciclovir: 5% - 6%
- vandetanib: 0.9%
- venlafaxine: rare, infrequent
- vincristine
- vinflunine
- vismodegib
- vorinostat
- zanamivir
- ziprasidone: infrequent
- zoledronic acid: postmarketing, 0.6% - 2.5%
- zolmitriptan: rare
- zonisamide: infrequent
- zopiclone: rare
|
Drugs with this indication
|
